Showing 4131-4140 of 9942 results for "".
- Successful Topline Results Seen for Hallura's New BiOLinkMatrix HA Aesthetic Fillershttps://practicaldermatology.com/news/successful-topline-results-seen-for-halluras-new-biolinkmatrix-ha-aesthetic-fillers/2461096/Hallura Ltd’s hyaluronic acid (HA) dermal fillers with its proprietary BiOLinkMatrix platform performed well for lip enhancement, nasolabial folds correction. and cheek enhancement, according to topline results. The proprietary Bi
- Study: Retinol Plus CBD Maintains Anti-Aging Properties Minus Side Effectshttps://practicaldermatology.com/news/study-retinol-plus-cbd-maintains-anti-aging-properties-minus-side-effects/2461059/Combining a retinol and cannabidiol (CBD) in topical skincare maintains retinol’s anti-aging properties with reduced side effects, a new study in Aesthetic Sur
- Foods High in Sugar and Fat Disrupt the Gut Microbiome and Trigger Psoriasis Flareshttps://practicaldermatology.com/news/foods-high-in-sugar-and-fat-disrupt-the-gut-microbiome-and-trigger-psoriasis-flares/2460846/Diets rich in sugar and fat may lead to an imbalance in the gut’s microbial culture and contribute to inflammatory skin diseases such as psoriasis, according to a new study in the Journal o
- Research Brief: Personalized Bacteriotherapy May Improve Skin Microbiome and Symptoms in ADhttps://practicaldermatology.com/news/research-brief-personalized-bacteriotherapy-may-improve-skin-microbiome-and-symptoms-in-ad/2460841/Bacteriotherapy with an autologous strain of bacteria may safely improve S. aureus colonization in the microbiome of patients with atopic dermatitis (AD) and improve disease severity, a
- SkinSAFE, CVS Name Top 25 2021 Sunscreen Award Winners for Sensitive Skinhttps://practicaldermatology.com/news/skinsafe-cvs-name-top-25-2021-sunscreen-award-winners-for-sensitive-skin/2460826/SkinSAFE partnered with CVS Pharmacy, through the retailer's "Sensitive-Friendly" program, for the first-ever awards that recognize popular products that are safe for sensitive skin types. The experts at
- Pediatric Dermatology Incomes Up; Demand Persists: Surveyhttps://practicaldermatology.com/news/pediatric-dermatology-incomes-up-demand-persists-survey/2460735/Median total compensation for pediatric dermatologists has increased 37 percent since 2014, results of The Society for Pediatric Dermatology’s (SPD) latest compensation report show. The
- Launching from Nutrafol: New Pro-Strength Boostershttps://practicaldermatology.com/news/launching-from-nutrafol-new-pro-strength-boosters/2460713/New professional-strength boosters from Nutrafol extend the popular nutraceutical line, providing physicians the opportunity to individualize recommendations for each patient’s specific hair health needs. Hairbiotic MD is a professional-strength
- DermTech Adds to Scientific Advisory Boardhttps://practicaldermatology.com/news/dermtech-adds-to-scientific-advisory-board/2460686/Drs. Lisa Beck and George Han are the newest members of DermTech’s Scientific Advisory Board, Lisa Beck, MD, is the co-director of the University of Rochester Medical Center for Allergic Disease Research a
- FDA Defers Approval of Revance's Toxin Due to COVID-19 Related Travel Restrictions Impacting Manufacturing Site Inspectionhttps://practicaldermatology.com/news/fda-defers-approval-of-revances-toxin-due-to-covid-19-related-travel-restrictions-impacting-manufacturing-site-inspection/2460628/The U.S. Food and Drug Administration (FDA) deferred a decision on the Biologics License Application (BLA) for Revance’s DaxibotulinumtoxinA for Injection, an investigational neuromodulator product for the treatment of moderate to severe glabellar lines. In a communication r
- Bristol Myers Squibb's Deucravacitinib Performs Well in Phase 2 Study in Patients with Psoriatic Arthritishttps://practicaldermatology.com/news/bristol-myers-squibbs-deucravacitinib-performs-well-in-phase-2-study-in-patients-with-psoriatic-arthritis/2460605/Results from an ongoing Phase 2 study evaluating the safety and efficacy of Bristol Myers Squibb's deucravacitinib (BMS-986165) 6mg or 12mg once daily, compared with placebo in